Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease

Autor: Hong Jiang, Ye-sen Zhu, Qifang Li, Hui Xu, Yu Sun
Rok vydání: 2010
Předmět:
Lipopolysaccharides
Male
Vascular Endothelial Growth Factor A
Pyrrolidines
Immunoblotting
Biophysics
Administration
Oral

Pharmacology
Biochemistry
Antioxidants
Pulmonary function testing
Rats
Sprague-Dawley

chemistry.chemical_compound
Pulmonary Disease
Chronic Obstructive

Pyrrolidine dithiocarbamate
Thiocarbamates
Smoke
Tobacco
medicine
Animals
Lung
COPD
medicine.diagnostic_test
business.industry
Reverse Transcriptase Polymerase Chain Reaction
NF-kappa B
General Medicine
Hypoxia (medical)
medicine.disease
Hypoxia-Inducible Factor 1
alpha Subunit

respiratory tract diseases
Rats
Respiratory Function Tests
Vascular endothelial growth factor
Vascular endothelial growth factor A
Bronchoalveolar lavage
chemistry
Hypoxia-inducible factors
Immunology
Cytokines
medicine.symptom
Blood Gas Analysis
business
Bronchoalveolar Lavage Fluid
Heme Oxygenase-1
Zdroj: Acta biochimica et biophysica Sinica. 42(7)
ISSN: 1745-7270
Popis: Accumulating data suggested that hypoxia inducible factor (HIF)-1alpha plays an important role in the evolution and propagation of the inflammatory process. To characterize the activation of HIF-1alpha in rats with chronic obstructive pulmonary disease (COPD) and examine the possible role of nuclear factor (NF)-kappaB in this process, rats were challenged by introtracheal instillation of lipopolysaccharide (LPS) and exposure to cigarette smoke. Pyrrolidine dithiocarbamate (PDTC) was administered via the oral route 1 h before LPS or cigarettes administration. Four weeks later, pulmonary function and histology were tested; bronchoalveolar lavage fluid (BALF) and arterial blood gases were assayed. Activation of pulmonary NF-kappaB was assessed by quantitative PCR, immunoblot analysis, and electrophoretic mobility shift assay, respectively. Results showed that LPS and smog induced the characteristics of COPD seen in human. PDTC alleviated the development of COPD and the levels of cytokines in BALF of PDTC+COPD group were significantly decreased compared with that of COPD group. The activation of pulmonary NF-kappaB was inhibited by PDTC and the accumulation of HIF-1alpha gene expression in the COPD group was attenuated by PDTC pretreatment. Furthermore, the mRNA levels of HIF-1alpha target genes heme oxygenase-1 (HO-1) and vascular endothelial growth factor (VEGF) were parallel to the attenuation of HIF-1alpha by PDTC. These findings indicated that the activation of HIF-1alpha pathway via NF-kappaB contributes to the development of COPD, and administration of NF-kappaB inhibitor may attenuate the development of COPD.
Databáze: OpenAIRE